# Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia

> **NCT02824380** · PHASE1 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Androgenic Alopecia

## Interventions

- **DRUG:** DA-4001 H
- **DRUG:** DA-4001 L

## Key facts

- **NCT ID:** NCT02824380
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2018-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02824380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02824380, "Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02824380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*